Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Oncology Reports
|
May 21, 2011
Growth-control of human ovarian-carcinoma cells by insulin-like growth-factors
J M Bartlett, G J Rabiasz, W N Scott, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 9, 1998
Transforming growth factor-beta isoform expression in human ovarian tumours
J M Bartlett, S P Langdon, W N Scott, et al.
Cancer Research
|
July 1, 1985
Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent
J A Hickman, M F Stevens, N W Gibson, et al.
Cancer Research
|
November 1, 1988
Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines
S P Langdon, M M Hawkes, F G Hay, et al.
British Journal of Cancer
|
August 1, 1992
Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cells
G J Rabiasz, S P Langdon, J M Bartlett, et al.
British Journal of Cancer
|
August 1, 1990
Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines
S P Langdon, M M Hawkes, S S Lawrie, et al.
International Journal of Cancer
|
September 30, 1993
Contrasting effects of 17 beta-estradiol on the growth of human ovarian carcinoma cells in vitro and in vivo
S P Langdon, A Ritchie, K Young, et al.
Cancer Research
|
November 15, 1987
Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine
M F Stevens, J A Hickman, S P Langdon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 1998
Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen
S P Langdon, H Gabra, J M Bartlett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 1995
Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer
H Gabra, S P Langdon, J E Watson, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Oncology Reports
|
May 21, 2011
Growth-control of human ovarian-carcinoma cells by insulin-like growth-factors
J M Bartlett, G J Rabiasz, W N Scott, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 9, 1998
Transforming growth factor-beta isoform expression in human ovarian tumours
J M Bartlett, S P Langdon, W N Scott, et al.
Cancer Research
|
July 1, 1985
Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent
J A Hickman, M F Stevens, N W Gibson, et al.
Cancer Research
|
November 1, 1988
Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines
S P Langdon, M M Hawkes, F G Hay, et al.
British Journal of Cancer
|
August 1, 1992
Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cells
G J Rabiasz, S P Langdon, J M Bartlett, et al.
British Journal of Cancer
|
August 1, 1990
Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines
S P Langdon, M M Hawkes, S S Lawrie, et al.
International Journal of Cancer
|
September 30, 1993
Contrasting effects of 17 beta-estradiol on the growth of human ovarian carcinoma cells in vitro and in vivo
S P Langdon, A Ritchie, K Young, et al.
Cancer Research
|
November 15, 1987
Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine
M F Stevens, J A Hickman, S P Langdon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 1998
Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen
S P Langdon, H Gabra, J M Bartlett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 1995
Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer
H Gabra, S P Langdon, J E Watson, et al.
Page
of 8